PuraStat®

DEVICE4 trials

Sponsors

Portsmouth Hospitals NHS Trust, 3-D Matrix Europe SAS

Conditions

Delayed BleedingGastrointestinal BleedingGastrointestinal HaemorrhageLiver ResectionVascular Anastomosis Surgery

Unknown Phase

Purastat® vs Standard Therapy for Haemostasis During Endoscopic Submucosal Dissection

CompletedNCT02833558

Portsmouth Hospitals NHS TrustGastrointestinal Haemorrhage

Start: 2016-05-04End: 2018-05-18Updated: 2018-06-26

Post-market Clinical Study to Confirm Safety and Performance of PuraStat® for the Management of Bleeding in Vascular Surgery.

CompletedNCT03103282

3-D Matrix Europe SASVascular Anastomosis Surgery

Start: 2017-06-14End: 2019-08-30Updated: 2020-12-10

Post-Market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Liver Surgery

3-D Matrix Europe SASLiver Resection

Start: 2018-08-02End: 2020-02-29Updated: 2019-09-09

A Evaluation of the Utilisation, Effectiveness and Safety of Purastat® in the Management of Gastrointestinal Bleeding

CompletedNCT03983707

Portsmouth Hospitals NHS TrustDelayed Bleeding, Gastrointestinal Bleeding

Start: 2019-01-23End: 2021-10-31Updated: 2025-05-31

Related Papers

Effectiveness and safety of a haemostatic gel in the treatment of intraprocedural bleeding and prevention of delayed bleeding after advanced endoscopic resection of large and complex gastrointestinal neoplasia: a multicentre prospective observational PuraStat study

Frontline Gastroenterology2026-01-16